retatrutide cardiovascular Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide and Heart Issues: Cardiovascular

GLP-1 reduces hunger by Slowing gastric emptying Increasing satiety signals Blunting appetite drive This is why people eat less not because of discipline. GIP helps improve metabolic efficiency and insulin response

It launched under the brand name Mounjaro for diabetes management in 2022 and Zepbound for weight loss in 2023

Inject into the subcutaneous tissue of the middle third of the thigh, roughly midway between the knee and hip, on the front or outer side

To participate in the model, state Medicaid programs must sign a State Agreement with CMS and then adopt supplemental rebate agreements (SRAs) with each participating manufacturer that reflects the standard key terms that the participating manufacturers and CMS have agreed to